AGM
CBAY
Alpine Global Management’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-197,888
| Closed | -$584K | – | 515 |
|
|
2022
Q2 | $584K | Sell |
197,888
-52,112
| -21% | -$154K | 0.15% | 73 |
|
|
2022
Q1 | $778 | Hold |
250,000
| – | – | 0.18% | 85 |
|
|
2021
Q4 | $845K | Buy |
+250,000
| New | +$845K | 0.12% | 168 |
|
|
2021
Q1 | – | Sell |
-25,339
| Closed | -$145K | – | 375 |
|
|
2020
Q4 | $145K | Buy |
+25,339
| New | +$145K | 0.03% | 141 |
|
|
2018
Q2 | – | Sell |
-14,933
| Closed | -$194K | – | 125 |
|
|
2018
Q1 | $194K | Sell |
14,933
-18,864
| -56% | -$245K | 0.05% | 88 |
|
|
2017
Q4 | $311K | Buy |
+33,797
| New | +$311K | 0.07% | 105 |
|